The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labour

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 561-571

  Grammatopoulos, Dimitris K ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

CRH receptor; Labor; Myometrium; Review; Urocortin

Indexed keywords

MAMMALIA;

EID: 34249778102     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2082     Document Type: Article

References (67)

1. Vale W, J. Spiess, C. Rivier & J. Rivier: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397 (1981)
2. Vaughan J, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, S. Sutton, R. Chan, A.V. Turnbull, D. Lovejoy, C. Rivier, J. Rivier, & W. Vale: Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-92 (1995)
3. Reyes T.M, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale & P.E. Sawchenko: Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98, 2843-8 (2001)
4. Lewis K, C. Li, M.H. Perrin, A. Blount, K. Kunitake, C. Donaldson, J. Vaughan, T.M. Reyes, J. Gulyas, W. Fischer, L. Bilezikjian, J. Rivier, P.E. Sawchenko & W.W. Vale: Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98, 7570-5 (2001)
5. Petraglia F, P.E. Sawchenko, J. Rivier & W. Vale: Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 328, 717-9 (1987)
6. Petraglia F, P. Florio, R. Gallo, T. Simoncini, M. Saviozzi, A.M. Di Blasio, J. Vaughan & W. Vale: Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81, 3807-10 (1996)
7. Karteris E, M. Vatish, E.W. Hillhouse & D.K. Grammatopoulos: Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J Clin Endocrinol Metab 90, 3680-7 (2005)
8. McLean M, A. Bisits, J. Davies, R. Woods, P. Lowry& R. Smith: A placental clock controlling the length of human pregnancy. Nat Med 1, 460-463 1995
9. Clifton V.L., Q. Gu, V.E. Murphy, J. Schwartz, G. Madsen & R. Smith: Localization and characterization of urocortin during human pregnancy. Placenta 21, 782-8 (2000)
10. Korebrits C, M.M. Ramirez, L. Watson, E. Brinkman, A.D. Bocking & J.R. Challis: Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 83, 1585-91 (1998)
11. Kemp C.F, R.J. Woods & P.J. Lowry: The corticotrophin-releasing factor-binding protein: an act of several parts. Peptides 19: 1119-28 (1998)
12. Petraglia F, E. Potter, V.A. Cameron, S. Sutton, D.P. Behan, R.J. Woods, P.E. Sawchenko, P.J. Lowry & W. Vale: Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 77, 919-24 (1993)
13. Behan D.P, E.B. De Souza, P.J. Lowry, E. Potter, P. Sawchenko & W.W. Vale: Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 16, 362-82 (1995)
14. Goland R.S, S.L. Wardlaw, R.I.Stark, L.S. Brown Jr & A.G. Frantz: High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 63, 1199-203 (1986)
15. Ackland J.F, S.J. Ratter, G.L. Bourne & L.H. Rees Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami. J Endocrinol 108, 171-80 (1986)
16. Erickson K, P. Thorsen, G. Chrousos, D.E. Grigoriadis, O. Khongsaly, J. McGregor & J. Schulkin: Preterm birth: associated neuroendocrine, medical, and behavioral risk factors. J Clin Endocrinol Metab 86, 2544-52 (2001)
17. Grammatopoulos D & E.W. Hillhouse: Role of corticotropin-releasing hormone in the onset of labour. Lancet 353, 1546-49 (1999)
18. Clifton V.L, M.A. Read, I.M. Leitch, A.L. Boura, P.J. Robinson & R. Smith: Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab 79, 666-9 (1994)
19. Jones S.A & J.R. Challis: Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochem Biophys Res Commun 159: 192-9 (1989)
20. Sirianni R, K.S. Rehman, B.R. Carr, C.R. Parker Jr & W.E. Rainey: Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J Clin Endocrinol Metab 90: 279-85 (2005)
21. Chen R, K.A. Lewis, M.H. Perrin & W.W. Vale: Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90, 8967-71 (1993)
22. Lovenberg T.W, C.W. Liaw, D.E. Grigoriadis, W. Clevenger, D.T. Chalmers, E.B. De Souza & T. Oltersdorf: Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92, 836-40 (1995)
23. Ross P.C, C.M. Kostas & T.V. Ramabhadran: A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem Biophys Res Commun 205, 1836-42 (1994)
24. Grammatopoulos D.K, Y. Dai, H.S. Randeva, M.A. Levine, E. Karteris, AJ. Easton & E.W. Hillhouse: novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol 13, 2189-202 (1999)
25. Pisarchik A & A.T Slominski: Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15, 2754-6 (2001)
26. Pisarchik A & A. Slominski: Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur J Biochem 271:2821-30 (2004)
27. Shyu J-F, D. Inoue, R. Baron & W.C. Horne: The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occuring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C. J Biol Chem 271, 31127-31134 (1996)
28. Kishimoto T, R.V. Pearse, C.R. Lin & M.G. Rosenfeld: A sauvagine/corticotropin -releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92, 1108-1112 (1995)
29. Valdenaire O, T. Giller, V. Breu, J. Gottowik & G. Kilpatrick: A new functional isoform of the human CRF2 receptor for corticotropin-releasing hormone. Biochim Biophys Acta 1352, 129-132 (1997)
30. Kostich W.A, A. Chen, K. Sperle & B.L. Largent: Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF27 receptor. Mol Endocrinol 12, 1077-1085 (1998)
31. Catalano R.D, T. Kyriakou, J. Chen, A. Easton & B.W. Hillhouse: Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol 17, 395-410 (2003)
32. Miyata I, C. Shiota, S. Chaki, S. Okuyama & T. Inagami: Localization and characterization of a short isoform of the corticotropin-releasing factor receptor type 2alpha (CRF(2)alpha-tr) in the rat brain. Biochem Biophys Res Commun 280, 553-7 (2001)
33. Chen A.M, M.H Perrin, M.R. Digruccio, J.M. Vaughan, B.K. Brar, C.M. Arias, K.A. Lewis, J.E. Rivier, P.E. Sawchenko & W.W. Vale: A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci USA 102, 2620-5 (2005)
34. Parham K.L, S. Zervou, E. Karteris, R.D. Catalano, R.W. Old & E.W. Hillhouse: Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin. Endocrinology 145, 3971-83 (2004)
35. Karteris E, E.W. Hillhouse & D. Grammatopoulos: Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. Endocrinology 145, 890-900 (2004)
36. Grammatopoulos D, S. Thompson & E.W. Hillhouse: The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J Clin Endocrinol Metab 80: 2388-93 (1995)
37. Grammatopoulos D, Y. Dai, J. Chen, E. Karteris, N. Papadopoulou, A.J. Easton & E.W. Hillhouse: Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 83, 2539-44 (1998)
38. Stevens M.Y, J.R. Challis & S.J. Lye: Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labor in the human myometrium. J Clin Endocrinol Metab 83, 4107-15 (1998)
39. Hillhouse E.W, D. Grammatopoulos, N.G. Milton & H.W. Quartero: The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metab 76, 736-41 (1993)
40. Grammatopoulos D, N.G. Milton & E.W. Hillhouse: The human myometrial CRH receptor: G proteins and second messengers. Mol Cell Endocrinol 99, 245-50 (1994)
41. Hertelendy F, & T. Zakar: Regulation of myometrial smooth muscle functions. Curr Pharm Des 10, 2499-517 (2004)
42. Mesiano S, E.C. Chan, J.T. Fitter, K. Kwek, G. Yeo & R. Smith: Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 87, 2924-30 (2002)
43. R.A. Word: Myosin phosphorylation and the control of myometrial contraction/relaxation. Semin Perinatol 19:3-14 (1995)
44. Somlyo A.P & A.V. Somlyo: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522, 177-85 (2000)
45. Somlyo A.P & A.V. Somlyo: From pharmacomechanical coupling to G-proteins and myosin phosphatase. Ada Physiol Scand 164, 437-48 (1998)
46. Benedetto C, F. Petraglia, L. Marozio, L. Chiarolini, P. Florio, A.R. Genazzani & M. Massobrio: Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. Am J Obstet Gynecol 171:126-31 (1994)
47. Petraglia F, P. Florio, C. Benedetto, L. Marozio, A.M. Di Blasio, C. Ticconi, E. Piccione, S. Luisi, A.R. Genazzani & W. Vale: Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metab 84, 1420-3 (1999)
48. Quartero H.W & C.H. Fry: Placental corticotrophin releasing factor may modulate human parturition. Placenta 10, 439-43 (1989)
49. Mignot T.M., B. Paris, B. Carbonne, C. Vauge, F. Ferre & D. Vaiman: Corticotropin-releasing hormone effects on human pregnant vs. nonpregnant myometrium explants estimated from a mathematical model of uterine contraction. J Appl Physiol 99, 1157-63 (2005)
50. Aggelidou E, E.W. Hillhouse & D. Grammatopoulos: Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin releasing hormone in cultured human pregnant myometrial cells. Proc Natl Acad Sci USA 99, 3300-3305 (2002)
51. 301 for signalling switch and selectivity. Mol Endocrinol 18, 624-39 (2004)
52. Yue C, K.L. Dodge, G. Weber & B.M. Sanborn: Phosphorylation of serine 1105 by protein kinase A inhibits phospholipase Cbeta3 stimulation by Galphaq. J Biol Chem 273: 18023-7 (1998)
53. Grammatopoulos D.K, H.S. Randeva, M.A. Levine, K.A. Kanellopoulou & E.W. Hillhouse: Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem 76, 509-19 (2001)
54. Randeva H.S, D.K. Grammatopoulos &E.W. Hillhouse: Differential activation of G-Proteins by CRH and Urocortin in human pregnant myometrium. 81th Annual Meeting of the Endocrine Society, San Diego, P3-460 (1999)
55. Europe-Finner G.N, S. Phaneuf, A.M. Tolkovsky, S.P. Watson & A. Lopez Bernal: Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab 79, 1835-9 (1994)
56. Grammatopoulos D, G.M. Stirrat, S.A. Williams & E.W. Hillhouse: The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J Clin Endocrinol Metab 81: 745-51 (1996)
57. Warren W.B, E.D. Gurewitsch & R.S. Goland: Corticotropin-releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertension. Am J Obstet Gynecol 172, 661-6 (1995)
58. Grammatopoulos D.K & E.W. Hillhouse: Basal and interleukin-1 beta-stimulated prostaglandin production from cultured human myometrial cells: differential regulation by corticotropin-releasing hormone. J Clin Endocrinol Metab 84, 2204-11 (1999)
59. Pollard J.K & M.D. Mitchell: Intrauterine infection and the effects of inflammatory mediators on prostaglandin production by myometrial cells from pregnant women. Am J Obstet Gynecol 174, 682-6 (1996)
60. Grammatopoulos D & E.W. Hillhouse: Activation of protein kinase C by oxytocin inhibits the biological activity of the human myometrial corticotropin-releasing hormone receptor at term. Endocrinology 140, 585-94 (1999)
61. Fuchs AR, F. Fuchs, P. Husslein, M.S. Soloff & M.J. Fernstrom: Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 215, 1396-8 (1982)
62. Grammatopoulos D, M.A. Levine, A. Simpson & E.W. Hillhouse: Differences between CRH-R1 alpha and CRH-Rlbeta response to PKC but not PKA-induced phosphorylation and desensitization. J Endocrinol, 160 (Suppl): P179 (1999)
63. Grammatopoulos D.K, H.S. Randeva, M.A. Levine, E.S. Katsanou & E.W. Hillhouse: Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1 alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol Endocrinol 14, 2076-91 (2000)
64. I. Wickelgren: Premature labor. Resetting pregnancy's clock. Science 304, 666-8 (2004)
65. Keller P.A, K. Kirkwood, J. Morgan, S. Westcott & A. McCluskey: The prevention of preterm labour - corticotropin releasing hormone type 1 receptors as a target for drug design and development. Mini Rev Med Chem 3, 295-303 (2003)
66. Chan E.C, J. Falconer, G. Madsen, K.C. Rice, E.L. Webster, G.P. Chrousos & R. Smith: A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep. Endocrinology 139, 3357-60 (1998)
67. Funai E.F, L.M. O'Neill, A. Davidson, H. Roque & T.H. Finlay: A corticotropin releasing hormone receptor antagonist does not delay parturition in rats. J Perinat Med 28, 294-7 (2000)